Using Western blot, the authors found that, in HT-29 CD133+ cells, knockdown of Prx2 decreased and overexpression of Prx2 increased the expression of SMO and Gli1 proteins, suggesting Prx2 might regulate cancer stem cell properties via Hedgehog/Gli1 pathway [69]. Here, GLI1 is linked to cancer.